Skip to main content

Peakadilly Wins $2.2M from Flanders Government to Develop Protein Biomarker Platform


NEW YORK (GenomeWeb News) – The Flanders government has extended a grant to Peakadilly to speed up development of its biomarker discovery platform, the Belgian company said today.
 
The company plans to use the funds, which total €1.7 million ($2.2 million), to expand relationships with pharma and diagnostic companies and to accelerate development of its own diagnostic products.
 
Peakadilly's biomarker discovery platform is based on its MASStermind techonology, which includes mass spectrometry techniques and data interpretation methods.
 
The Institute for the Promotion of Innovation by Science and Technology in Flanders made the grant extension.
 
In August, Peakadilly raised $10.9 million in venture capital funding.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.